Thursday, October 23, 2014 7:29:18 PM
"We have used the falls to get more Grifols and Applus"
BEGOÑA BEARD ALBA MADRID 10.20.2014 7:33
Recommend on Facebook 2Tweet 8Send to LinkedIn 5
PRINT OUT
Related Topics:
EDM ManagementGrifolsGathered TechniquesIndraCatalana OccidenteMutual fundsFinancial marketsBusinessEconomyFinance
Estabanell Antonio, CEO of EDM.
MARTA YORDI
It is one of the oldest Spanish managers, with 25 years of life. Of Catalan origin, a specialist in Spanish and European equities and a pioneer in alternative investment. In late September administered 2,400 million.
Question. What are the main strengths of EDM?
Answer . Independence. Our sole aim is to offer good long-term results for our clients. As managers we have a selection based on individual assets in the portfolio, looking for companies that can grow, having good fundamental valuations but paying the right price style.
Q. After a week of vertigo in the stock market, do you think that falls mark a turnaround or are punctual?
R. 're in a very nervous market, which at the slightest wobble there are important corrections for psychological reasons we are nothing more than opportunities. We have seized falls to reinforce positions in securities with good long-term prospects, as Grifols, Applus, Essentra or Aggreko.
Q. How will behave markets?
R . We believe that given the situation in Europe, with such stagnant growth, monetary policy rates so low, rather than a country approach will be a large scatter in the prices of securities. We can have the stock of a country with shares having an excellent behavior with other nefarious behavior. The banking sector will behave similarly in different countries, since their results depend more on how the macroeconomic situation work.
Q. What are your favorite settings?
R . A value that is strongly Acerinox have bet, because it is a company that has done its homework. We like, as I said, Grifols, Catalana Occidente, Techniques Gathered and Indra. We believe that good deeds give good long-term results. We currently have more Spanish portfolio values ??at other times.
Q. And in Europe, what are your bets?
R . We weighted Roche. We see great opportunities in Capita Group, British company outsourcing and the German software giant SAP.
Q. In your opinion, how does the behavior of the bond?
R . The situation will be fixed very low yields for some time. The investor has to be aware of the environment in which we are, which are very low and even negative inflation. You have to look at real interest rates.
P. His connection to Catalonia, do you harm?
R . We do not position ourselves as a manager of Catalonia. We deposited vehicles in Ireland and Luxembourg. Our investment scope is global. The fact that our management team is in Barcelona is an anecdote.
Q. What changes in taxation?
R . We positively lowering of taxation on capital gains. Regarding income, we do not believe that there will be much decrease in taxation of the middle segments of the tax. Regarding Plan May expect their development. It does not seem very attractive need to be transformed into an annuity. We believe that increase individual pension funds.
EDM Management is present in Spain, Ireland, Luxembourg and the past year in Latin America funds sold through two American trading platforms, Pershing and DBH.
Q. Why have entered Latin America?
R. We felt that our expertise in security selection and management style was transferable to that geographical area initially but European values ??have launched a fund that invests in Latin American stocks. We manage 200 million euros there.
Q. What values ??provide more travel puddle jumping?
R . Dufry, a company of Swiss origin, but gives sales services in major Latin American airports. We also betting on the Brazilian bank Itaú and cosmetics firm Natura. And in Chile Falabella.
P. The political situation in Venezuela, Bolivia or Argentina, can affect the Spanish firms involved in the markets?
R. There are important uncertainties for companies operating in those countries. However, the consolidation of political systems can have very sustained growth in Peru, Colombia and Mexico.
P. Son of the pioneers in alternative investment, this business is dead?
R. With the financial crisis has changed much alternative investments. For private banks is probably dead because it is difficult to understand for the customer, but not for institutions. The volume of assets between institutional has increased and currently manage 80 million euros.
Recent GRFS News
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/25/2024 09:15:19 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 09/23/2024 09:10:48 PM
- Apollo Eyes $5 Billion Investment in Intel; TSMC and Samsung Explore UAE Chip Projects, and More • IH Market News • 09/23/2024 10:32:25 AM
- Schwab and Snowflake Retreat in Premarket, WeRide Postpones IPO, Halliburton Cyberattack, McDonald’s Instagram Hack • IH Market News • 08/22/2024 09:37:42 AM
- GigaGen Receives FDA Clearance of IND Application for Phase 1 Trial of Recombinant Polyclonal for HBV Treatment, GIGA-2339 • GlobeNewswire Inc. • 07/31/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/30/2024 06:00:13 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 07/30/2024 03:12:47 PM
- Grifols receives expanded XEMBIFY® (immune globulin subcutaneous human-klhw) label in U.S., strengthening its Ig portfolio for patients • GlobeNewswire Inc. • 07/29/2024 12:00:00 PM
- Apple Joins OpenAI Board, Logitech President Opts Out of Reelection, and More News • IH Market News • 07/03/2024 10:59:39 AM
- Grifols’ Biotest to achieve USD 1 billion in US sales of Yimmugo® over next seven years • GlobeNewswire Inc. • 07/01/2024 10:00:44 AM
- Grifols completes sale of a 20% equity stake in SRAAS and forges strategic alliance with Haier Group • GlobeNewswire Inc. • 06/18/2024 11:30:08 AM
- Grifols’ Biotest receives FDA approval for innovative Yimmugo® immunoglobulin to treat primary immunodeficiencies • GlobeNewswire Inc. • 06/17/2024 08:20:00 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/14/2024 09:00:41 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 06/04/2024 02:51:31 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 05/31/2024 08:46:16 PM
- Grifols 2023 Annual Report on Form 20-F filed with the SEC • PR Newswire (US) • 04/19/2024 08:42:00 PM
- Grifols Celebrates 50 Years of Manufacturing Life-Changing Plasma-Derived Medicines for Patients at Flagship Site in Clayton, N.C. • GlobeNewswire Inc. • 04/18/2024 01:30:00 PM
- Samsung Surpasses Apple in Q1 Smartphone Market; Salesforce in Talks to Acquire Informatica, and More News • IH Market News • 04/15/2024 11:06:48 AM
- Grifols Procleix ArboPlex Assay® Receives CE Mark, the First and Only 4-in-1 NAT for Arbovirus Screening • GlobeNewswire Inc. • 04/04/2024 08:00:00 AM
- FedEx Soars 13% with Profits Above Forecasts, Nike Hit by China Slowdown, and Latest News • IH Market News • 03/22/2024 01:07:53 PM
- CNOOC Oil Field Discovery in South China Sea, Grifols Surges 18% After KPMG Approval, and Latest News • IH Market News • 03/08/2024 11:19:59 AM
- Grifols announces positive topline phase 3 fibrinogen clinical trial results • GlobeNewswire Inc. • 02/14/2024 08:16:43 AM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/26/2024 10:14:35 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/16/2024 11:05:11 AM
- Wall Street Highlights: DocuSign Acquisition Battle, Tesla Berlin Production Halt, and More • IH Market News • 01/12/2024 11:10:50 AM
North Bay Resources Commences Operations at Bishop Gold Mill, Inyo County, California; Engages Sabean Group Management Consulting • NBRI • Sep 25, 2024 9:15 AM
CEO David B. Dorwart Anticipates a Bright Future at Good Gaming Inc. Through His Most Recent Shareholder Update • GMER • Sep 25, 2024 8:30 AM
Cannabix Technologies and Omega Laboratories Inc. Advance Marijuana Breathalyzer Technology - Dr. Bruce Goldberger to Present at Society of Forensic Toxicologists Conference • BLOZF • Sep 24, 2024 8:50 AM
Integrated Ventures, Inc Announces Strategic Partnership For GLP-1 (Semaglutide) Procurement Through MedWell USA, LLC. • INTV • Sep 24, 2024 8:45 AM
Avant Technologies Accelerates Creation of AI-Powered Platform to Revolutionize Patient Care • AVAI • Sep 24, 2024 8:00 AM
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM